Aligos Therapeutics

5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra
BioSpace
Mon, 04/15/24 - 11:24 am
MASH
NASH
Madrigal Pharmaceuticals
Rezdiffra
Ionis Pharmaceuticals
ION224
Altimmune
pemvidutid
89Bio
pegozafermin
Viking Therapeutics
VK2809
Aligos Therapeutics
ALG-055009
Hepatitis B drug developers chart slow progress forward, just like hep C before it
Fierce Biotech
Tue, 11/14/23 - 09:35 am
hepatitis B
hepatitis C
drug development
Assembly Biosciences
GSK
Aligos Therapeutics
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more
MedCity News
Mon, 03/28/22 - 10:17 am
FDA
Pfizer
etrasimod
Argenxy
efgartigimod
Aligos Therapeutics
Vallon Pharmaceuticals
Adderall
ORIC Pharmaceuticals
ORIC-101
Neurana Pharmaceuticals
tolperisone
Eli Lilly
sintilimab
Aligos Takes Another Hit with Halt of Hep B Therapy
BioSpace
Wed, 03/23/22 - 10:31 am
Aligos Therapeutics
hepatitis B
ALG-020572
adverse events
clinical trials
Aligos says stop right now to lead hep B med after fruitless phase 1 data
Fierce Biotech
Thu, 01/6/22 - 11:56 pm
Aligos Therapeutics
hepatitis B
clinical trials
Four biotechs and a Matthew Roden-led SPAC price IPOs, raising a combined $528M
Endpoints
Fri, 10/16/20 - 12:16 pm
IPOs
biotech
SPAC
Matthew Roden
Praxis Precision Medicines
Tarsus Pharmaceuticals
Aligos Therapeutics
Kiromic Biopharma
Tumeric Acquisition
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
Xconomy
Mon, 09/28/20 - 10:27 pm
Praxis Precision Medicines
Aligos Therapeutics
Tarsus Therapeutics
IPOs